A carregar...

Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer

Through metabolic subtyping, metabolic vulnerabilities can be exploited for developing efficacious treatments. A glycolytic subtype indicates poor survival in pancreatic cancer patients, whereas a cholesterogenic subtype correlates with better outcomes potentially due to more energy expenditure. Per...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Mehla, Kamiya, Singh, Pankaj K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942627/
https://ncbi.nlm.nih.gov/pubmed/31628144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2926
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!